Stanford reports human cortical organoids occupy cortex and hippocampus in genetically modified mice

Pașca's group engineered mice lacking most endogenous cortical and hippocampal cells, then transplanted human brain organoids postnatally. The human cells proliferated and integrated across the species barrier, occupying the vacated space within weeks to months. Mutant mice without transplants showed normal locomotion but failed spatial memory tasks; transplanted animals performed closer to wild-type controls on maze retention tests.

Prior Pașca work demonstrated organoid survival and basic function in neonatal rodents. The current data extend that result by quantifying behavioral rescue and confirming extensive axonal connectivity. Charlesworth's commentary notes the scale of interspecies integration but provides no quantitative metrics on synapse density or circuit topology beyond the reported maze scores.

The protocol avoids primates, consistent with Pașca's stated boundary on species choice. No data address long-term circuit stability, seizure thresholds, or EEG signatures in the chimeric animals. Operational use is framed for modeling cortical injury rather than cognitive enhancement.

Next steps include scaling organoid size and testing targeted injury models. Publication records show no follow-on primate proposals in the 18 months after submission.